Annual long term liabilities:
$3.12B+$1.16B(+59.12%)Summary
- As of today (August 23, 2025), VRTX annual total long term liabilities is $3.12 billion, with the most recent change of +$1.16 billion (+59.12%) on December 31, 2024.
- During the last 3 years, VRTX annual long term liabilities has risen by +$1.93 billion (+161.77%).
- VRTX annual long term liabilities is now at all-time high.
Performance
VRTX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$2.72B+$121.90M(+4.69%)Summary
- As of today (August 23, 2025), VRTX quarterly total long term liabilities is $2.72 billion, with the most recent change of +$121.90 million (+4.69%) on June 30, 2025.
- Over the past year, VRTX quarterly long term liabilities has increased by +$912.70 million (+50.42%).
- VRTX quarterly long term liabilities is now at all-time high.
Performance
VRTX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VRTX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +59.1% | +50.4% |
| 3 y3 years | +161.8% | +149.2% |
| 5 y5 years | +246.9% | +203.1% |
VRTX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +161.8% | at high | +155.1% |
| 5 y | 5-year | at high | +246.9% | at high | +203.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
VRTX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.72B(+4.7%) |
| Mar 2025 | - | $2.60B(+78.2%) |
| Dec 2024 | $3.12B(+59.1%) | $1.46B(-44.6%) |
| Sep 2024 | - | $2.64B(+45.6%) |
| Jun 2024 | - | $1.81B(+14.9%) |
| Mar 2024 | - | $1.57B(+27.6%) |
| Dec 2023 | $1.96B(+30.9%) | $1.23B(-23.6%) |
| Sep 2023 | - | $1.61B(+5.7%) |
| Jun 2023 | - | $1.53B(+0.7%) |
| Mar 2023 | - | $1.52B(+1.3%) |
| Dec 2022 | $1.50B(+25.7%) | $1.50B(+40.1%) |
| Sep 2022 | - | $1.07B(-2.3%) |
| Jun 2022 | - | $1.09B(-6.5%) |
| Mar 2022 | - | $1.17B(-1.8%) |
| Dec 2021 | $1.19B(+0.3%) | $1.19B(+1.4%) |
| Sep 2021 | - | $1.17B(-1.3%) |
| Jun 2021 | - | $1.19B(-0.2%) |
| Mar 2021 | - | $1.19B(+0.3%) |
| Dec 2020 | $1.19B(+32.2%) | $1.19B(+2.0%) |
| Sep 2020 | - | $1.16B(+29.6%) |
| Jun 2020 | - | $898.49M(+0.6%) |
| Mar 2020 | - | $892.80M(-0.6%) |
| Dec 2019 | $898.39M(+30.1%) | $898.39M(+3.0%) |
| Sep 2019 | - | $872.26M(+23.9%) |
| Jun 2019 | - | $704.29M(-1.3%) |
| Mar 2019 | - | $713.33M(+3.3%) |
| Dec 2018 | $690.40M(-0.9%) | $690.40M(+488.5%) |
| Sep 2018 | - | $117.32M(+1.6%) |
| Jun 2018 | - | $115.53M(-0.9%) |
| Mar 2018 | - | $116.64M(+3.6%) |
| Dec 2017 | $696.45M(-9.1%) | $112.55M(-3.8%) |
| Sep 2017 | - | $117.03M(-51.8%) |
| Jun 2017 | - | $242.59M(-1.0%) |
| Mar 2017 | - | $244.98M(+0.1%) |
| Dec 2016 | $766.06M(-14.8%) | $244.72M(+40.9%) |
| Sep 2016 | - | $173.67M(-1.1%) |
| Jun 2016 | - | $175.67M(+10.7%) |
| Mar 2016 | - | $158.72M(-0.4%) |
| Dec 2015 | $898.79M(+3.3%) | $159.40M(-9.2%) |
| Sep 2015 | - | $175.47M(-4.8%) |
| Jun 2015 | - | $184.36M(+130.0%) |
| Mar 2015 | - | $80.14M(+3.7%) |
| Dec 2014 | $870.24M(+54.1%) | $77.31M(-91.2%) |
| Sep 2014 | - | $878.00M(+50.7%) |
| Jun 2014 | - | $582.58M(-1.7%) |
| Mar 2014 | - | $592.73M(+4.9%) |
| Dec 2013 | $564.81M(-48.3%) | $564.81M(+121.8%) |
| Sep 2013 | - | $254.62M(-4.6%) |
| Jun 2013 | - | $266.83M(-55.0%) |
| Mar 2013 | - | $593.01M(+44.7%) |
| Dec 2012 | $1.09B(+29.1%) | $409.69M(-36.7%) |
| Sep 2012 | - | $647.35M(+11.3%) |
| Jun 2012 | - | $581.54M(+20.3%) |
| Mar 2012 | - | $483.45M(+23.7%) |
| Dec 2011 | $846.65M(+13.4%) | $390.70M(+1.0%) |
| Sep 2011 | - | $386.73M(-8.7%) |
| Jun 2011 | - | $423.77M(+28.2%) |
| Mar 2011 | - | $330.62M(-4.6%) |
| Dec 2010 | $746.69M(+30.0%) | $346.69M(-21.2%) |
| Sep 2010 | - | $439.94M(-1.9%) |
| Jun 2010 | - | $448.28M(+1.2%) |
| Mar 2010 | - | $442.83M(-2.1%) |
| Dec 2009 | $574.26M(+9.4%) | $452.49M(-3.8%) |
| Sep 2009 | - | $470.54M(+22.8%) |
| Jun 2009 | - | $383.14M(-2.3%) |
| Mar 2009 | - | $392.23M(-25.3%) |
| Dec 2008 | $525.04M | $525.04M(-2.3%) |
| Sep 2008 | - | $537.20M(-2.0%) |
| Jun 2008 | - | $547.99M(+33.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $411.93M(+214.7%) |
| Dec 2007 | $130.90M(-20.5%) | $130.90M(-4.7%) |
| Sep 2007 | - | $137.41M(-4.3%) |
| Jun 2007 | - | $143.58M(-9.8%) |
| Mar 2007 | - | $159.21M(-3.3%) |
| Dec 2006 | $164.63M(-21.4%) | $164.63M(-29.3%) |
| Sep 2006 | - | $232.89M(-31.9%) |
| Jun 2006 | - | $341.75M(+63.1%) |
| Mar 2006 | - | $209.50M(-0.0%) |
| Dec 2005 | $209.58M(-41.2%) | $209.58M(-29.1%) |
| Sep 2005 | - | $295.45M(-12.1%) |
| Jun 2005 | - | $335.96M(-2.5%) |
| Mar 2005 | - | $344.55M(-3.3%) |
| Dec 2004 | $356.27M(-9.2%) | $356.27M(-2.6%) |
| Sep 2004 | - | $365.60M(-2.8%) |
| Jun 2004 | - | $376.31M(-3.8%) |
| Mar 2004 | - | $391.25M(-0.3%) |
| Dec 2003 | $392.50M(+5.4%) | $392.50M(+0.2%) |
| Sep 2003 | - | $391.57M(+1.1%) |
| Jun 2003 | - | $387.42M(+1.0%) |
| Mar 2003 | - | $383.75M(+3.0%) |
| Dec 2002 | $372.54M(+4.0%) | $372.54M(+2.3%) |
| Sep 2002 | - | $364.07M(+0.7%) |
| Jun 2002 | - | $361.51M(+0.5%) |
| Mar 2002 | - | $359.85M(+0.5%) |
| Dec 2001 | $358.23M(+13.3%) | $358.23M(+1.1%) |
| Sep 2001 | - | $354.19M(+2.2%) |
| Jun 2001 | - | $346.63M(-0.1%) |
| Mar 2001 | - | $346.97M(-2.9%) |
| Dec 2000 | $316.13M(+6636.2%) | $357.27M(+2.6%) |
| Sep 2000 | - | $348.12M(+94.9%) |
| Jun 2000 | - | $178.62M(-0.3%) |
| Mar 2000 | - | $179.16M(+3717.5%) |
| Dec 1999 | $4.69M(-33.3%) | $4.69M(-9.8%) |
| Sep 1999 | - | $5.20M(-10.3%) |
| Jun 1999 | - | $5.80M(-9.4%) |
| Mar 1999 | - | $6.40M(-8.6%) |
| Dec 1998 | $7.03M(+19.2%) | $7.00M(-7.9%) |
| Sep 1998 | - | $7.60M(+10.1%) |
| Jun 1998 | - | $6.90M(+11.3%) |
| Mar 1998 | - | $6.20M(+5.1%) |
| Dec 1997 | $5.90M(+5.9%) | $5.90M(+9.3%) |
| Sep 1997 | - | $5.40M(0.0%) |
| Jun 1997 | - | $5.40M(+1.9%) |
| Mar 1997 | - | $5.30M(-5.4%) |
| Dec 1996 | $5.57M(+13.5%) | $5.60M(+27.3%) |
| Sep 1996 | - | $4.40M(-2.2%) |
| Jun 1996 | - | $4.50M(+2.3%) |
| Mar 1996 | - | $4.40M(-10.2%) |
| Dec 1995 | $4.91M(+4.5%) | $4.90M(0.0%) |
| Sep 1995 | - | $4.90M(-2.0%) |
| Jun 1995 | - | $5.00M(0.0%) |
| Mar 1995 | - | $5.00M(+6.4%) |
| Dec 1994 | $4.70M(+12.6%) | $4.70M(+2.2%) |
| Sep 1994 | - | $4.60M(+4.5%) |
| Jun 1994 | - | $4.40M(+15.8%) |
| Mar 1994 | - | $3.80M(-9.5%) |
| Dec 1993 | $4.17M(+26.7%) | $4.20M(+5.0%) |
| Sep 1993 | - | $4.00M(+5.3%) |
| Jun 1993 | - | $3.80M(+11.8%) |
| Mar 1993 | - | $3.40M(+6.3%) |
| Dec 1992 | $3.29M(+51.3%) | $3.20M(0.0%) |
| Sep 1992 | - | $3.20M(+6.7%) |
| Jun 1992 | - | $3.00M(+30.4%) |
| Mar 1992 | - | $2.30M(+4.5%) |
| Dec 1991 | $2.18M(-9.3%) | $2.20M(-4.3%) |
| Sep 1991 | - | $2.30M(-8.0%) |
| Jun 1991 | - | $2.50M(+4.2%) |
| Dec 1990 | $2.40M | $2.40M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total long term liabilities?
- What is the all time high annual long term liabilities for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual long term liabilities year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly long term liabilities year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total long term liabilities?
The current annual long term liabilities of VRTX is $3.12B
What is the all time high annual long term liabilities for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total long term liabilities is $3.12B
What is Vertex Pharmaceuticals Incorporated annual long term liabilities year-on-year change?
Over the past year, VRTX annual total long term liabilities has changed by +$1.16B (+59.12%)
What is Vertex Pharmaceuticals Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of VRTX is $2.72B
What is the all time high quarterly long term liabilities for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total long term liabilities is $2.72B
What is Vertex Pharmaceuticals Incorporated quarterly long term liabilities year-on-year change?
Over the past year, VRTX quarterly total long term liabilities has changed by +$912.70M (+50.42%)